ibopamine vs placebo | No demonstrated result suggested Sudden death by 50% (not demonstrated) | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
---|
Sudden death | 1.50 [1.02 2.20] | p=0.04 | 0 | 1906 | 1 | PRIME II, | Worsening heart failure | no data | Transplantation | 0.95 [0.52 1.75] | p=1.00 | 0 | 1906 | 1 | PRIME II, | Arrhythmia | no data | Vertigo | no data | Death from any cause or hospitalization for heart failure | no data | myocardial infarction (fatal and non fatal) | no data | cardiac death | 0.71 [0.37 1.39] | p=1.00 | 0 | 1906 | 1 | PRIME II, | All cause death | 1.20 [0.97 1.49] | p=1.00 | 0 | 1906 | 1 | PRIME II, | TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |